CVM- Q1 Data Release and Beautiful Wedge Forming

CVM has an update coming up on their drug for head and neck cancer, Multikine. This alone tells you that this is a good stock to own in March. The fact that they are forming a bullish flag formation already is a little surprising, but I will definitely enter this week. Look to hold throughout March and watch out for the press release. Good luck!